Cardiovascular Drugs — MCQs

Cardiovascular Drugs Indian Medical PG Practice Questions and MCQs

Question 701: In a patient with concomitant diabetes, what is the anti-hypertensive agent of choice?

A. Calcium channel blocker
B. Beta adrenergic blocker
C. ACE inhibitor (Correct Answer)
D. Plasma kinins

Explanation: **Explanation:** **1. Why ACE Inhibitors are the Correct Choice:** ACE inhibitors (e.g., Enalapril, Ramipril) are the drugs of choice for hypertensive patients with diabetes mellitus primarily due to their **renoprotective effects**. They cause preferential dilatation of the **efferent arteriole** in the kidney, which reduces intraglomerular pressure. This mechanism effectively slows the progression of diabetic nephropathy and reduces albuminuria (microalbuminuria). Additionally, ACE inhibitors are metabolically neutral and may slightly improve insulin sensitivity. **2. Why Other Options are Incorrect:** * **Calcium Channel Blockers (CCBs):** While CCBs (like Amlodipine) are metabolically neutral and effective anti-hypertensives, they do not offer the same level of superior renal protection as ACE inhibitors or ARBs. They are considered second-line or add-on therapy. * **Beta Adrenergic Blockers:** These are generally avoided as first-line therapy in diabetics because they can **mask the warning symptoms of hypoglycemia** (tachycardia, tremors) and may impair glucose tolerance by inhibiting insulin release. * **Plasma Kinins:** These are endogenous peptides (like bradykinin) involved in inflammation and vasodilation. They are not used as pharmacological agents for treating hypertension. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** If a patient has both Diabetes and Hypertension, the first choice is an **ACE Inhibitor**. If the patient develops a dry cough (due to bradykinin accumulation), switch to an **ARB** (Losartan/Telmisartan). * **Mechanism:** ACE inhibitors reduce **Proteinuria**, which is the hallmark of diabetic kidney disease. * **Contraindications:** Never prescribe ACE inhibitors or ARBs during **pregnancy** (teratogenic) or in patients with **Bilateral Renal Artery Stenosis**. * **Electrolyte Watch:** Always monitor for **Hyperkalemia** when starting these drugs.

Question 702: All of the following statements about the antianginal action of nitrates are true EXCEPT?

A. Decreased myocardial O2 consumption
B. Decreased both preload and afterload
C. Increased total coronary flow (Correct Answer)
D. Cause favorable redistribution of coronary flow

Explanation: **Explanation** The primary mechanism of nitrates in treating stable angina is **not** an increase in total coronary blood flow, but rather a reduction in myocardial oxygen demand. **1. Why "Increased total coronary flow" is the correct (False) statement:** In patients with coronary artery disease, the coronary vessels are already maximally dilated due to local metabolic factors (autoregulation). Nitrates do not significantly increase the *total* volume of blood flowing through these stenosed vessels. Instead, their benefit comes from reducing the workload of the heart and redistributing the existing flow. **2. Analysis of other options:** * **Decreased myocardial O2 consumption (A):** This is the **primary** antianginal effect. By causing systemic vasodilation, nitrates reduce the work the heart must do, thereby lowering oxygen demand. * **Decreased both preload and afterload (B):** Nitrates are potent venodilators (decreasing **preload** by increasing venous pooling) and, at higher doses, arteriolar dilators (decreasing **afterload**). Preload reduction is their most prominent effect. * **Favorable redistribution of coronary flow (D):** Nitrates dilate the large epicardial conductance vessels without causing "coronary steal." This helps redistribute blood from the epicardium to the **sub-endocardium**, which is the area most vulnerable to ischemia. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Nitrates are prodrugs that release **Nitric Oxide (NO)**, which activates guanylyl cyclase, increasing **cGMP** and leading to dephosphorylation of myosin light chains (relaxation). * **Drug of Choice:** Sublingual Nitroglycerin is the drug of choice for **acute** anginal attacks. * **Nitrate Tolerance:** Continuous exposure leads to a loss of effect (depletion of free sulfhydryl groups). A "nitrate-free interval" of 8–12 hours (usually at night) is required to prevent this. * **Contraindication:** Never co-administer with **Sildenafil** (PDE-5 inhibitors) as it can cause life-threatening hypotension.

Question 703: Nitrates cannot be used in which of the following conditions?

A. Angina pectoris
B. Biliary colic
C. Renal colic (Correct Answer)
D. Cyanide poisoning

Explanation: **Explanation:** Nitrates are potent smooth muscle relaxants that act by releasing Nitric Oxide (NO), which increases cGMP levels. However, their efficacy varies across different organ systems. **Why Renal Colic is the Correct Answer:** Nitrates are **ineffective in renal colic** because the ureteric smooth muscle lacks the specific metabolic machinery or sufficient sensitivity to respond to nitrate-induced relaxation. In clinical practice, renal colic is managed with NSAIDs (to decrease prostaglandin-mediated pressure) and antispasmodics like hyoscine or tamsulosin. **Analysis of Incorrect Options:** * **Angina Pectoris:** This is the primary indication for nitrates. They cause peripheral vasodilation (venodilation > arteriodilation), which decreases preload and myocardial oxygen demand. * **Biliary Colic:** Nitrates effectively relax the **Sphincter of Oddi** and the smooth muscles of the biliary tract, providing symptomatic relief in biliary spasms. * **Cyanide Poisoning:** Amyl nitrite and sodium nitrite are used as antidotes. They induce **methemoglobinemia**; methemoglobin has a high affinity for cyanide, forming cyanmethemoglobin and preventing cyanide from binding to cytochrome oxidase. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** For acute angina, sublingual Nitroglycerin (GTN) is the DOC. * **Nitrate Tolerance:** Continuous use leads to "tachyphylaxis" due to the depletion of free sulfhydryl (-SH) groups. A "nitrate-free interval" of 8–12 hours (usually at night) is required to prevent this. * **Monday Disease:** Workers in dynamite factories experience headaches and dizziness on Mondays due to sudden re-exposure to nitrates after a weekend break. * **Contraindication:** Never co-administer nitrates with **Sildenafil** (PDE-5 inhibitors) as it can lead to life-threatening hypotension.

Question 704: Betaxolol is a:

A. alpha blocker
B. beta blocker (Correct Answer)
C. calcium channel blocker
D. None of the above

Explanation: **Explanation:** **Betaxolol** is a highly selective **$\beta_1$-adrenergic receptor antagonist** (cardioselective beta-blocker). It works by competitively inhibiting the action of catecholamines on $\beta_1$ receptors located primarily in the heart and the juxtaglomerular apparatus of the kidney [1]. * **Why Option B is Correct:** Betaxolol belongs to the second generation of beta-blockers [1]. Its high selectivity for $\beta_1$ receptors makes it useful in treating hypertension and glaucoma while minimizing side effects related to $\beta_2$ blockade (like bronchospasm). * **Why Option A is Incorrect:** Alpha-blockers (e.g., Prazosin, Phenoxybenzamine) act on $\alpha$-adrenergic receptors [2]. Betaxolol has no significant $\alpha$-blocking activity. * **Why Option C is Incorrect:** Calcium channel blockers (e.g., Amlodipine, Verapamil) inhibit the influx of calcium ions into cardiac and smooth muscle cells. While they are also used for hypertension, their mechanism of action is distinct from beta-blockers. **High-Yield Clinical Pearls for NEET-PG:** 1. **Glaucoma Management:** Betaxolol is unique because it is one of the few **cardioselective** beta-blockers available as an ophthalmic solution. It reduces intraocular pressure by decreasing aqueous humor production. 2. **Safety Profile:** Due to its $\beta_1$ selectivity, it is preferred over non-selective blockers (like Timolol) in patients with mild respiratory issues, though caution is still advised in severe asthma/COPD. 3. **Pharmacokinetics:** It has a long half-life (~14–22 hours), allowing for convenient once-daily dosing. 4. **Membrane Stabilizing Activity (MSA):** Betaxolol possesses slight MSA, but it lacks Intrinsic Sympathomimetic Activity (ISA).

Question 705: Which of the following is associated with a prolonged QT interval?

A. Hypercalcemia
B. Type Ia antiarrhythmic drugs (Correct Answer)
C. Torsade de pointes
D. Atrial fibrillation

Explanation: **Explanation:** The **QT interval** on an ECG represents the duration of ventricular depolarization and repolarization. Prolongation of this interval is primarily caused by a delay in ventricular repolarization, usually due to the inhibition of outward potassium ($K^+$) currents. **Why Option B is Correct:** **Type Ia antiarrhythmic drugs** (e.g., Quinidine, Procainamide, Disopyramide) act by blocking fast sodium ($Na^+$) channels, but they also possess significant **potassium channel blocking** properties. By inhibiting the efflux of $K^+$ during phase 3 of the cardiac action potential, they delay repolarization, thereby lengthening the action potential duration (APD) and the QT interval. **Analysis of Incorrect Options:** * **A. Hypercalcemia:** High calcium levels actually **shorten** the QT interval by accelerating the plateau phase (Phase 2) of the action potential. Conversely, *hypocalcemia* causes QT prolongation. * **C. Torsade de pointes (TdP):** This is a **consequence**, not a cause, of a prolonged QT interval. TdP is a specific type of polymorphic ventricular tachycardia that occurs when a prolonged QT interval leads to early after-depolarizations (EADs). * **D. Atrial fibrillation:** This is a supraventricular tachyarrhythmia characterized by disorganized atrial electrical activity. While it affects the rhythm and the absence of P-waves, it does not inherently prolong the QT interval. **NEET-PG High-Yield Pearls:** * **Mnemonic for QT Prolonging Drugs (ABCDE):** **A**ntiarrhythmics (Class Ia & III), **B**iotics (Macrolides, Fluoroquinolones), **C**yps (Antipsychotics/Haloperidol), **D**epressants (TCAs, SSRIs), **E**metics (Ondansetron). * **Electrolyte triggers:** Hypokalemia, hypomagnesemia, and hypocalcemia all prolong the QT interval. * **Treatment of TdP:** Intravenous **Magnesium Sulfate** is the drug of choice, even if serum magnesium levels are normal.

Question 706: Which of the following is true regarding enalapril treatment in patients of essential hypertension?

A. Decreased angiotensin II concentration in the blood (Correct Answer)
B. Decreased concentration of renin in the blood
C. Decreases sodium and increases potassium in the urine
D. All of the above

Explanation: **Explanation:** Enalapril is an **ACE (Angiotensin-Converting Enzyme) Inhibitor**. To understand its effects, one must look at the Renin-Angiotensin-Aldosterone System (RAAS) pathway. **1. Why Option A is Correct:** ACE inhibitors directly block the enzyme responsible for converting Angiotensin I into **Angiotensin II**. Therefore, the primary biochemical effect of enalapril is a significant **decrease in circulating Angiotensin II levels**. This leads to vasodilation and decreased peripheral resistance. **2. Why the other options are incorrect:** * **Option B:** ACE inhibitors actually **increase plasma renin levels**. Because Angiotensin II levels fall, the negative feedback loop on the juxtaglomerular cells is lost, leading to a compensatory rise in renin secretion (pro-renin to renin). * **Option C:** By decreasing Angiotensin II, there is a subsequent decrease in **Aldosterone** secretion. Since aldosterone normally causes sodium reabsorption and potassium excretion, inhibiting it leads to **increased sodium excretion (natriuresis)** and **decreased potassium excretion** in the urine. This results in a risk of hyperkalemia, not increased potassium in the urine. **High-Yield Clinical Pearls for NEET-PG:** * **Bradykinin:** ACE inhibitors also inhibit the breakdown of bradykinin. Increased bradykinin levels are responsible for the classic side effects: **Dry cough** and **Angioedema**. * **Teratogenicity:** ACE inhibitors are strictly contraindicated in pregnancy as they cause **fetal renal anomalies** (Potter sequence). * **Drug of Choice:** They are the first-line treatment for hypertension in patients with **Diabetes Mellitus** (due to nephroprotective effects) and **Heart Failure** (reduces remodeling). * **First-dose phenomenon:** Watch out for sudden hypotension after the first dose, especially in patients on diuretics.

Question 707: Ibutilide acts by

A. Blockade of Na+ current
B. Interference with the action of catecholamines at the beta-adrenergic receptor (Correct Answer)
C. Delay of repolarization due to inhibition of K+ current
D. Interference with calcium conductance

Explanation: **Explanation:** The question asks for the mechanism of action of **Ibutilide**. However, based on the provided answer key, there is a discrepancy between the drug name and the mechanism. **1. Understanding the Correct Answer (Option B):** The mechanism "Interference with the action of catecholamines at the beta-adrenergic receptor" describes **Class II Antiarrhythmics (Beta-blockers)**. If the question intended to ask about a drug like Propranolol or Esmolol, Option B would be correct. **2. Understanding Ibutilide (The Actual Pharmacology):** In standard pharmacology (Vaughan-Williams classification), **Ibutilide is a Class III Antiarrhythmic.** Its primary mechanism is: * **Option C (Delay of repolarization due to inhibition of K+ current):** This is the classic Class III action. Ibutilide specifically blocks the rapid component of the delayed rectifier potassium current ($I_{Kr}$). * **Unique Action:** Unlike other Class III drugs, Ibutilide also acts by **promoting the inward Sodium ($Na^+$) current** (late slow inward current) during the action potential plateau. Both actions lead to a prolonged action potential duration and QT interval. **3. Why other options are incorrect:** * **Option A:** Describes **Class I** agents (e.g., Lidocaine, Flecainide) which block fast $Na^+$ channels. * **Option D:** Describes **Class IV** agents (e.g., Verapamil, Diltiazem) which are Calcium Channel Blockers. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Ibutilide is the drug of choice for the **rapid pharmacological cardioversion** of recent-onset Atrial Flutter and Atrial Fibrillation. * **Side Effect:** The most serious risk is **Torsades de Pointes** (due to QT prolongation), occurring in up to 6% of patients. * **Mnemonic for Class III:** "**S**illy **A**mi **D**rinks **I**ce **D**ofetillide" (**S**otalol, **A**miodarone, **D**ronedarone, **I**butilide, **D**ofetilide).

Question 708: Which of the following statements is relevant when deciding to treat a patient with procainamide?

A. Procainamide may worsen or precipitate hyperthyroidism.
B. Procainamide is not effective for atrial arrhythmias.
C. Procainamide prolongs the effective refractory period in atrial and ventricular cells. (Correct Answer)
D. Procainamide commonly induces thrombocytopenia.

Explanation: **Explanation:** **Procainamide** is a **Class IA antiarrhythmic** agent. Its primary mechanism of action involves blocking voltage-gated sodium channels (state-dependent) and, significantly, blocking potassium channels [1]. By inhibiting outward potassium currents during repolarization, it increases the action potential duration (APD) and **prolongs the effective refractory period (ERP)** in both atrial and ventricular myocytes [1], [2]. This makes it effective for treating both supraventricular and ventricular arrhythmias [3]. **Analysis of Incorrect Options:** * **Option A:** This is incorrect. **Amiodarone**, not procainamide, is the drug associated with thyroid dysfunction (both hypo- and hyperthyroidism) due to its high iodine content and structural similarity to thyroxine. * **Option B:** This is incorrect. Procainamide is a versatile antiarrhythmic used for **both atrial and ventricular arrhythmias**, including the conversion of atrial fibrillation in Wolff-Parkinson-White (WPW) syndrome [3]. * **Option D:** While procainamide can cause blood dyscrasias (like agranulocytosis), it is not "commonly" associated with thrombocytopenia [4]. Its most famous hematologic/immunologic side effect is **Drug-Induced Lupus Erythematosus (DILE)** [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug-Induced Lupus:** Occurs in 25-30% of patients on long-term therapy. It is characterized by **Anti-Histone Antibodies** and typically spares the kidneys [3]. * **Metabolism:** It is acetylated by the liver enzyme **N-acetyltransferase** to **N-acetylprocainamide (NAPA)**. NAPA is an active metabolite that primarily has Class III properties [4]. * **ECG Changes:** Due to its Class IA properties, it causes prolongation of the **QRS complex and QT interval**, increasing the risk of Torsades de Pointes [4].

Question 709: Which of the following fibrinolytic agents is antigenic?

A. Urokinase
B. Alteplase
C. Tenecteplase
D. Streptokinase (Correct Answer)

Explanation: **Explanation:** The correct answer is **Streptokinase**. **1. Why Streptokinase is the correct answer:** Streptokinase is a protein derived from **Group C Beta-hemolytic Streptococci**. Because it is a bacterial product and not a human enzyme, the human immune system recognizes it as a foreign antigen. This leads to the production of antistreptococcal antibodies. * **Clinical Significance:** These antibodies can cause hypersensitivity reactions (ranging from rashes to anaphylaxis) and can neutralize the drug, making it ineffective if administered again within 6 months to a year of the initial dose or a recent streptococcal infection. **2. Why the other options are incorrect:** * **Urokinase:** It is a human enzyme naturally synthesized by the kidneys and found in urine. Since it is of human origin, it is non-antigenic. * **Alteplase (rt-PA):** This is a recombinant form of human tissue-type plasminogen activator [1]. Being identical to endogenous human t-PA, it does not elicit an immune response. * **Tenecteplase:** This is a genetically engineered mutant of Alteplase with a longer half-life and higher fibrin specificity [1]. Despite the modifications, it remains non-antigenic. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Streptokinase is an **indirect** plasminogen activator; it forms a 1:1 complex with plasminogen to activate it. In contrast, Alteplase and Tenecteplase are **direct** activators [1]. * **Fibrin Specificity:** Streptokinase is **non-fibrin specific**, leading to a "systemic lytic state" and a higher risk of bleeding compared to the fibrin-specific agents (Tenecteplase > Reteplase > Alteplase) [1]. * **Side Effect:** Hypotension is a common side effect unique to Streptokinase infusion. * **Drug of Choice:** Tenecteplase is currently the preferred agent for STEMI due to its bolus dosing and high fibrin specificity [1].

Question 710: Which of the following drugs decreases heart rate?

A. Propranolol (Correct Answer)
B. Isoprenaline
C. Dopamine
D. Dobutamine

Explanation: **Explanation:** The heart rate is primarily regulated by the autonomic nervous system acting on **$\beta_1$-adrenergic receptors** located in the SA node. **Propranolol (Correct Answer):** Propranolol is a **non-selective $\beta$-blocker** (antagonist). By blocking $\beta_1$ receptors in the heart, it inhibits the stimulatory effects of catecholamines, leading to a decrease in the slope of Phase 4 depolarization in pacemaker cells. This results in **negative chronotropy** (decreased heart rate) and negative inotropy (decreased contractility). **Why the other options are incorrect:** * **Isoprenaline:** A potent non-selective $\beta$-agonist ($\beta_1$ and $\beta_2$). It significantly **increases** heart rate by stimulating $\beta_1$ receptors. * **Dopamine:** At moderate to high doses, dopamine stimulates $\beta_1$ receptors (directly and via norepinephrine release), causing an **increase** in heart rate. * **Dobutamine:** A relatively selective $\beta_1$-agonist used as an inotropic agent. While its primary effect is increasing contractility, it also **increases** heart rate. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Propranolol is the DOC for performance anxiety (stage fright) and prophylaxis of migraine. * **Contraindication:** Avoid $\beta$-blockers in patients with **Bronchial Asthma** (due to $\beta_2$ blockade causing bronchospasm) and **Prinzmetal Angina** (due to unopposed $\alpha$-mediated vasoconstriction). * **Membrane Stabilizing Activity:** Propranolol possesses significant local anesthetic activity, though it is not used clinically for this purpose. * **Bradycardia Management:** If a $\beta$-blocker overdose causes symptomatic bradycardia, the specific antidote is **Glucagon**.

Practice by Chapter

Antihypertensive Agents

Practice Questions

Drugs for Heart Failure

Practice Questions

Antiarrhythmic Drugs

Practice Questions

Antianginal Agents

Practice Questions

Lipid-Lowering Drugs

Practice Questions

Anticoagulants and Antiplatelet Drugs

Practice Questions

Thrombolytic Agents

Practice Questions

Drugs Used in Pulmonary Hypertension

Practice Questions

Drugs Used in Shock

Practice Questions

Cardiovascular Effects of Non-Cardiovascular Drugs

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free